193 related articles for article (PubMed ID: 22742554)
41. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions.
Reddy HS; Keene CD; Chang SH; Jian-Amadi A; Cimino PJ
Exp Mol Pathol; 2017 Apr; 102(2):198-202. PubMed ID: 28161440
[TBL] [Abstract][Full Text] [Related]
43. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
44. Signet ring cell melanocytic nevus: report of a case over trichilemmal cyst and review of the literature.
Sabater Marco V; Escutia Muñoz B; Morera Faet A; Botella Estrada R
Am J Dermatopathol; 2012 Feb; 34(1):e10-4. PubMed ID: 22262365
[TBL] [Abstract][Full Text] [Related]
45. Differential expression of the intermediate filament peripherin in cutaneous neural lesions and neurotized melanocytic nevi.
Prieto VG; McNutt NS; Lugo J; Reed JA
Am J Surg Pathol; 1997 Dec; 21(12):1450-4. PubMed ID: 9414188
[TBL] [Abstract][Full Text] [Related]
46. Differences in tumor thickness between hematoxylin and eosin and Melan-A immunohistochemically stained primary cutaneous melanomas.
Drabeni M; Lopez-Vilaró L; Barranco C; Trevisan G; Gallardo F; Pujol RM
Am J Dermatopathol; 2013 Feb; 35(1):56-63. PubMed ID: 22688397
[TBL] [Abstract][Full Text] [Related]
47. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
[TBL] [Abstract][Full Text] [Related]
48. A case of giant bathing trunk naevus with neurofibroma-like change.
Whittam LR; Macdonald DM; Hay RJ
Clin Exp Dermatol; 1996 Mar; 21(2):167-9. PubMed ID: 8759211
[TBL] [Abstract][Full Text] [Related]
49. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
[TBL] [Abstract][Full Text] [Related]
50. Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi.
Florell SR; Bowen AR; Hanks AN; Murphy KJ; Grossman D
J Cutan Pathol; 2005 Jan; 32(1):45-9. PubMed ID: 15660660
[TBL] [Abstract][Full Text] [Related]
51. Unna's and Miescher's nevi: two different types of intradermal nevus: hypothesis concerning their histogenesis.
Yus ES; del Cerro M; Simón RS; Herrera M; Rueda M
Am J Dermatopathol; 2007 Apr; 29(2):141-51. PubMed ID: 17414435
[TBL] [Abstract][Full Text] [Related]
52. Compound melanocytic nevi with granular cell changes.
El-Gamal HM; Robinson-Bostom L; Saddler KD; Pan T; Mihm MC
J Am Acad Dermatol; 2004 May; 50(5):765-6. PubMed ID: 15097962
[TBL] [Abstract][Full Text] [Related]
53. MART-1 is a reliable melanocytic marker in lichen planus-like keratosis: a study on 70 cases.
Gavino AC; Woods MT; Andea AA
Am J Dermatopathol; 2011 Oct; 33(7):675-80. PubMed ID: 21885940
[TBL] [Abstract][Full Text] [Related]
54. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Stratigos A; Patereli A; Katsambas A
J Cutan Pathol; 2008 Sep; 35(9):799-808. PubMed ID: 18494826
[TBL] [Abstract][Full Text] [Related]
55. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
[TBL] [Abstract][Full Text] [Related]
57. Automated quantification of MART1-verified Ki67 indices by digital image analysis in melanocytic lesions.
Nielsen PS; Riber-Hansen R; Raundahl J; Steiniche T
Arch Pathol Lab Med; 2012 Jun; 136(6):627-34. PubMed ID: 22646269
[TBL] [Abstract][Full Text] [Related]
58. FLI-1/Melan-A dual stain is an alternative to PRAME in differentiating metastatic melanoma from nodal nevus: A monocentric retrospective study.
Zengin HB; Yildiz B; Pukhalskaya T; Smoller BR
J Cutan Pathol; 2023 Mar; 50(3):247-258. PubMed ID: 36454046
[TBL] [Abstract][Full Text] [Related]
59. Fascin expression in melanocytic lesions of the skin.
YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
[TBL] [Abstract][Full Text] [Related]
60. Balloon cell nevi of the conjunctiva: Clinicopathologic correlation and literature review.
Thompson JM; Bermudez-Magner JA; Barker NH; Payne D; Meghpara B; Dubovy SR
Surv Ophthalmol; 2015; 60(5):481-5. PubMed ID: 26002588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
